Friday, January 2, 2026 1/2/2026

ARTEMIS: Advancing Addiction Research and Treatment through Engagement with Rural Marylanders Impacted by PolySubstance Use

Award Number: R24DA061178
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 04/30/2029

Group Awards By:

View Award Description

ARTEMIS: Advancing Addiction Research and Treatment through Engagement with Rural Marylanders Impacted by PolySubstance Use - ABSTRACT. Despite the significant increase in overdose-related deaths in the past decade, there continues to be a substantial gap in getting services to the individuals who need it most, particularly for individuals with polysubstance use in rural areas. To bridge this gap, clinical research and services must incorporate perspectives of individuals with polysubstance use in rural areas—voices that are often neglected from the research process and care delivery decisions. This proposal builds upon our team’s expertise in developing patient research advisory boards to advance addiction treatment by developing a novel patient engagement resource center (ARTEMIS: Advancing Addiction Research and Treatment through Engagement with Rural Marylanders Impacted by PolySubstance Use). This proposal is directly responsive to patient feedback to create a novel patient engagement resource center focused on improving services for individuals with polysubstance use in rural areas. Our team has conducted preliminary work, including to: (1) establish an urban Research Advisory Committee of individuals with lived experience of substance use to inform and accelerate addiction research; and (2) capture patient-defined barriers to treatment and successful treatment outcomes. Our interdisciplinary team at UMD has a strong history of collaboration with communities and patients, including five rural county health departments, and has established an innovative network of clinical services throughout rural Maryland, including a unique mobile telemedicine unit offering telemedicine buprenorphine prescribing and peer recovery services. We have created a framework for peer-focused clinical research at these sites, led by MPIs Kattakuzhy and Magidson (R01DA057443), offering an opportunity to build upon this infrastructure for ARTEMIS. The overall aim is to establish a sustainable patient engagement resource center to advance patient-centered, integrated care models for polysubstance use in rural areas. Specific aims are to: 1) Form a patient advisory committee and consultation model focused on individuals with polysubstance use in rural areas, guided by the Framework for Continuous Patient and Stakeholder Engagement in Patient Centered Outcomes Research (PCOR); 2) Evaluate patient experiences with polysubstance use care delivery in rural areas to document perceived barriers, preferences and strategies for improving service delivery; 3) Conduct pilot projects designed in partnership with the PAC, with a proposed focus on: a) Understanding patient experiences of polysubstance use, including intentions for and patterns of use; and b) Identifying strategies for addressing social determinants of health and improving functional outcomes. These pilot studies were guided by our team’s preliminary research and patient input, and the study designs will ultimately be based on feedback from Aims 1 and 2. ARTEMIS will leverage the team’s unique strengths to engage in meaningful dialogue with patients with polysubstance use to create a national model for urban-rural academic-community partnerships, and re-center the patient experience of polysubstance use in clinical research and treatment.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Drug Use and Addiction Research Programs	000	2	12/18/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $417,587 )
2025	2025	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Drug Use and Addiction Research Programs	001	2	4/21/2025	NON-COMPETING CONTINUATION	$417,587
2025	2024	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Drug Use and Addiction Research Programs	000	1	4/21/2025	NEW	$0
														Subtotal = $417,587

Issue Date FY: 2024 ( Subtotal = $430,333 )
2024	2024	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Drug Use and Addiction Research Programs	000	1	6/25/2024	NEW	$430,333
														Subtotal = $430,333

Grand Total All Awards = $847,920

Top

All Categories

About

Search

Reports

Data Submission

Award Information

ARTEMIS: Advancing Addiction Research and Treatment through Engagement with Rural Marylanders Impacted by PolySubstance Use

Award Number: R24DA061178

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 04/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer